Skip to main content
Caplight Logo









Locksmith Bio Inc.

Locksmith Bio Inc.

Private
Dover, DelawareHealthcare & Life Scienceshttps://locksmithbio.org/

Last Round

VC Round

May 4, 2026

Total Funding Raised

$125,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Locksmith Bio Inc. is a biotechnology company that uses physics-based AI to map intrinsically disordered protein regions, revealing novel drug targets to accelerate early-stage drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

AI drug discoverydrug target discoveryintrinsically disordered proteinsIDPsundruggable proteinsphysics-based AIin silico drug discoveryAI biotechtarget identificationcomputational drug discoverydrug discovery platformprotein mappingligandable site identificationearly-stage drug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Locksmith Bio Inc. Comparables

Compare Locksmith Bio Inc. with similar companies based on industry and business-model similarity.

Locksmith Bio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Topos Bio
92%
Peptone
89%
Ventus Therapeutics
75%

Locksmith Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 4, 2026
AcceleratorDec 17, 2024

Locksmith Bio Inc. Investors

Notable investors and investment history

Locksmith Bio Inc. investors
InvestorRounds
Entrepreneurs FirstVC Round, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2026

    $2M round led by Entrepreneurs First.

  • Dec 17, 2024

    $125K round led by Entrepreneurs First.

Locksmith Bio Inc. Filings

Explore SEC and related filing metadata, where available.

Locksmith Bio Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Locksmith Bio Inc.'s valuation, stock price, and market status.

Is Locksmith Bio Inc. a public or private company?

Locksmith Bio Inc. is a private company.

What is the current stock price of Locksmith Bio Inc.?

Locksmith Bio Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Locksmith Bio Inc. worth (valuation)?

Valuation information for Locksmith Bio Inc. is not publicly available.

Can I buy Locksmith Bio Inc. stock?

Locksmith Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Locksmith Bio Inc.'s last funding round?

Locksmith Bio Inc.'s most recent funding round was VC Round on May 4, 2026.

Who are the main investors in Locksmith Bio Inc.?

Key investors in Locksmith Bio Inc. include Entrepreneurs First.

Will Locksmith Bio Inc. IPO soon?

No public IPO plans have been announced for Locksmith Bio Inc..

How can I track Locksmith Bio Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Locksmith Bio Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDover, Delaware
Year Founded2024
Last FundingMay 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?